Celltrion | 068270 - Fremdkapital

Aktienkurs
198,400.00
Täglich Wechseln
-7,600.00 -3.69%
Monatlich
-11.82%
Jährlich
14.35%
Q2 Prognose
194,979.00




Fremdkapital Veränderung Datum
Akebia Therapeutics USD 48.25M 609K 2025-12
Alaunos Therapeutics USD 4.47M 5.85M 2022-06
Avita Medical AUD 42.24M 1.25M 2024-12
Celltrion KRW 63.29B 4.01B 2025-09
Dianthus Therapeutics USD 0 0 2024-12
Ionis Pharmaceuticals USD 1.9B 1.87B 2025-12
IQVIA Holdings USD 13.88B 1.09B 2025-12
Moderna USD 610M 584M 2025-12
Organon & Co USD 8.78B 117M 2025-09
Revvity USD 2.63B 543K 2025-12
Tectonic Therapeutic USD 43K 57K 2025-12
Viatris USD 12.48B 7M 2025-12
Xeris Pharmaceuticals USD 220.33M 866K 2025-12